Lose Up to 22% Body Weight
Mounjaro in Kenya
Are you struggling to lose weight despite dieting, exercising, or even undergoing bariatric surgery? Mounjaro (Tirzepatide) may be the solution you’ve been waiting for. Nairobi Bariatric Center is proud to introduce Mounjaro in Kenya for weight loss, a new injectable medication that works to reduce appetite, improve insulin sensitivity, and support sustainable weight loss under expert medical care.

What is Mounjaro?
Mounjaro (generic name Tirzepatide) is a once-weekly injectable medication originally developed to manage type 2 diabetes. However, it has shown impressive results in clinical trials for weight loss, even among people without diabetes.
Mounjaro is unique because it targets two hormones involved in appetite and digestion:
GLP-1 (Glucagon-Like Peptide-1)
GIP (Glucose-Dependent Insulinotropic Polypeptide)
By mimicking both, it helps you feel full faster, reduces cravings, and slows down digestion—making it easier to stay on track with your weight goals.
How Mounjaro Works
Mounjaro is a once-weekly injection that helps you lose weight by targeting two key hormones—GLP-1 and GIP—that control hunger, fullness, and how your body uses food. It was first developed for diabetes but has now shown even greater weight loss results than Ozempic or Wegovy in clinical trials.
Here’s how it works in your body:
- Helps You Feel Full, Sooner
Mounjaro slows how fast food leaves your stomach, so you feel full with smaller meals. This helps reduce overall calorie intake—without needing willpower or restrictive diets. - Calms Cravings and Hunger
It works on the brain’s appetite centers, lowering the urge to snack or overeat. Patients often report fewer sugar cravings and less emotional eating. - Enhances Insulin & Metabolism
By activating GIP (a second hunger-regulating hormone), Mounjaro improves how your body handles sugar and fat. This supports better metabolism and fat loss—even in people without diabetes. - Leads to Powerful Weight Loss
In clinical trials, patients lost up to 22% of their body weight—more than any other weight loss injection available. Best results happen when Mounjaro is paired with lifestyle support and expert care. - Designed for Safe, Gradual Progress
We start you on a low dose and increase slowly to reduce side effects like nausea or fatigue. Our team monitors you closely and adjusts your plan as needed for maximum comfort and success.
Our Mounjaro Packages
Mounjaro Basic
Check package pricing below
Mounjaro Plus+
Check package pricing below
Is Mounjaro Right for You?
You may be eligible if:
- You have a BMI ≥30, or ≥27 with a health condition (e.g., diabetes, hypertension, PCOS)
- You’re struggling with appetite control or weight regain after bariatric surgery
- You’re ready to pair medication with lasting lifestyle changes
We do not recommend Mounjaro for:
- Pregnant or breastfeeding women
- Those with a history of medullary thyroid cancer (MTC) or MEN2
- Patients with severe GI disorders or pancreatitis history
Is Mounjaro Better Than Surgery (Bypass/Sleeve)?
Aspect | Mounjaro (Tirzepatide) | Bariatric Surgery |
---|---|---|
Average Weight Loss | Up to 22% of total body weight (with lifestyle changes) | 25–35% of total body weight (sustained) |
Time to Results | Slower — noticeable loss after 3–6 months | Faster — most weight lost in 6–12 months |
Mechanism | Hormonal — reduces appetite, improves insulin & metabolism | Surgical — reduces stomach size and/or alters digestion |
Sustainability | Requires continued medication or habit change | More durable, but requires lifelong support & supplements |
Side Effects | Nausea, fatigue, gallstones, appetite changes | Dumping syndrome, surgical risks, nutritional deficiencies |
Cost Over 5 Years | ~Ksh 4.5M (ongoing injections) | ~Ksh 1.78M (surgery + supplements) |
Best For | BMI 27–40, not ready for surgery, or post-surgery regain | Severe obesity (BMI ≥40 or ≥35 with comorbidities) |
Common Side Effects of Mounjaro
Side Effect | Why It Happens | Management Tips |
---|---|---|
Nausea | Mounjaro slows digestion, making the stomach feel overly full. | Start with a low dose. Eat smaller, bland meals. Avoid greasy or spicy foods. |
Vomiting | Delayed stomach emptying can cause food buildup and reflux. | Hydrate slowly, rest the stomach, avoid large meals or lying down after eating. |
Constipation | Food moves slower through the gut due to hormonal changes. | Increase fiber gradually, drink more water, stay active. |
Diarrhea | Changes in gut motility and microbiome function. | Avoid high-fiber or fatty foods early on. Stay hydrated with oral rehydration salts if needed. |
Bloating & Gas | Delayed digestion can lead to fermentation in the gut. | Eat slowly, avoid carbonated drinks and high-gas foods like beans or cabbage. |
Fatigue | Reduced food intake and blood sugar shifts affect energy levels. | Eat balanced meals, include enough protein, rest as your body adjusts. |
Mild Dizziness | Blood sugar or hydration changes, especially early in treatment. | Hydrate well, avoid skipping meals, rise slowly from sitting or lying down. |
Hair Thinning | Rapid weight loss can trigger temporary shedding (telogen effluvium). | Ensure enough protein, iron, and biotin in your diet. Discuss supplements if needed. |
Comparing Mounjaro Vs Ozempic
Aspect | Mounjaro (Tirzepatide) | Ozempic (Semaglutide) |
---|---|---|
Mechanism | Dual-action: GLP-1 + GIP receptor agonist | GLP-1 receptor agonist only |
Weight Loss (Clinical Trials) | Up to 22% body weight loss (SURMOUNT-1) | 10–15% body weight loss (STEP trials) |
Best For | Obese or overweight patients, with or without diabetes | Primarily for type 2 diabetes; also used off-label for weight loss |
Blood Sugar Impact | Stronger HbA1c reduction (~2.1%) | Moderate HbA1c reduction (~1.8%) |
Craving Control | More effective at reducing appetite and emotional eating | Effective, but some patients report plateaus |
Side Effects | Nausea, constipation, fatigue, rare thyroid/gallbladder risks | Similar profile, slightly fewer reports of severe nausea |
Cost in Kenya | Higher (Ksh 75,000–110,000/month depending on package) | Lower (Ksh 65,000–95,000/month depending on package) |
Availability at NBC | Available under Mounjaro Support & PCEH Program | Available under Ozempic & Ozempic + PCEH Packages |
Benefits of Choosing Nairobi Bariatric Center
At Nairobi Bariatric Center, your care goes beyond just prescribing the injection. You’ll receive:
- Expert consultation with our doctors
- 24/7 access to our clinical support team
- Personalized follow-up and coaching
- Education on how to safely administer the injection
- Ongoing support through our exclusive patient community
Whether you are beginning your weight loss journey or need support after bariatric surgery, our team is here for you every step of the way.
Frequently Asked Questions About Mounjaro in Kenya
Yes. While Mounjaro (Tirzepatide) is officially registered for type 2 diabetes, it is being used off-label for weight loss in eligible patients under medical supervision, just like in the U.S., Europe, and South Africa. At Nairobi Bariatric Center, it’s prescribed based on international obesity guidelines, with full oversight by trained doctors.
At Nairobi Bariatric Center, Mounjaro is available through two package options:
- Ksh 90,000/month for medication, reviews, and nutrition support
- Ksh 120,000/month for the full PCEH program (psychotherapy, food tracking, group therapy)
These prices reflect dose escalation, expert consultations, and patient support, which are critical to success and safety. Costs may vary depending on your dosage and response to treatment.
No. Mounjaro is a prescription-only medication and must be prescribed by a licensed clinician. Buying it without medical supervision can be unsafe and is strongly discouraged, especially due to its powerful effects on appetite, digestion, and insulin regulation.
Many patients do regain some weight if they stop Mounjaro without changing their eating habits. That’s why our program includes PCEH (Psychological Correction of Eating Habits) — to help you build new behaviors and maintain results after treatment ends. Sustainable success comes from medication + mindset change.
Mounjaro is ideal for people who:
- Are not ready or eligible for bariatric surgery
- Need support after weight regain post-surgery
- Have a BMI of 27–40 kg/m² with weight-related conditions
While surgery offers more dramatic results, Mounjaro is a non-invasive option that’s more accessible and safer for some patients. We’ll help you compare both and choose what’s right for your long-term goals.
Some patients notice reduced appetite within the first 1–2 weeks. Visible weight loss usually begins by weeks 4–6, with steady progress over several months. Clinical trials showed peak results (15–22% body weight loss) after about 12–18 months of consistent use and lifestyle change.
Yes, Mounjaro is often helpful for Kenyans with insulin resistance, type 2 diabetes, or PCOS. It improves blood sugar and hormonal balance in addition to weight loss. However, it must be carefully prescribed to avoid complications — especially if you’re already on other diabetic or hormonal medications.